Daejin Abidoye

Daejin Abidoye

Company: Gilead Sciences

Job title: SVP Oncology Therapeutics

Seminars:

Industry Leaders Panel Discussion – Reviewing the Last Year & Creating Strategies to Further Develop ADCs Through 2022 9:30 am

Reviewing how breakthroughs in 2021 are shaping the ADC industry What decision are industry pioneers making to ensure continued progress within the ADC space (technical and business/partnership decisions)? Outlining the biggest challenges that ADC drug developers are facing in taking drugs from the bench to bedside Discussing methods to bring ADCs to earlier-line treatmentRead more

day: Day One

Strategically Developing & Advancing ADCs 8:30 am

Providing an historical review of ADCs Overviewing the current ADC landscape Discussing the future of ADCs: Combinations and SequencingRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.